Stock futures ticked higher on Wednesday (July 9) as investors assessed the latest tariff signals from President Donald Trump ...

Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 4.1% in the morning session after the company announced ...

GLP-1 drugs alter taste perceptions, challenging food makers to adapt by enhancing umami flavours, balancing sweetness, and ...

The Hims & Hers wellness platform announced Wednesday it will soon offer a generic version of the weight loss drug semaglutide in Canada as Novo Nordisk's patent on its branded version, known as ...

A little over a year after celebrating its 30th anniversary in China with a major production upgrade, Novo Nordisk is back ...

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...

For many, the high cost of the pill means stopping is a matter of 'when,' not 'if.' Endocrinologists reveal the crucial steps ...

Also read | Man lost belly fat by just changing these 4 things: ‘My belly started to shrink when…’ GLP-1-based drugs such as ...

Tom Cowen has been in the fitness industry for more than 20 years and has seen various fads come and go. He fears the current ...

Technology will soon make it possible to develop cheap, widely accessible psychoactive substances that are not harmful in the ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...